Phase 3 N=68 Randomized Single-blind Treatment

Clinical Performance of a Chlorhexidine Antimicrobial Dressing

Catheterization

Bottom Line

View on ClinicalTrials.gov: NCT00516906 ↗

Enrolled (actual)

Serious AEs

6.7%

Results posted

Feb 2012

Primary outcome: Primary: Clinician Overall Satisfaction With Catheter Securement — 2.27; 1.63 Units on a scale

Study Design & Population

Study type: Interventional
Phase: Phase 3
Interventions: Chlorhexidine gluconate (Drug); Transparent Adhesive Dressing (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Solventum US LLC
Primary completion: Dec 2007

Outcome Measures

Outcome	Result	p-value
PRIMARY Clinician Overall Satisfaction With Catheter Securement	2.27; 1.63	—
SECONDARY Clinician Overall Satisfaction With Dressing	2.20; 1.63	—
SECONDARY Rating of Skin Condition	0.1; 0.2	—

Summary

Evaluate the clinical performance of a new IV Dressing in Comparison to a standard IV Dressing

Eligibility Criteria

Inclusion Criteria

Males or Females over 18 years of age
Patients with an existing, or newly inserted, central venous catheter
Patients who require the catheter for at least 3 days

Exclusion Criteria

Sensitivity to chlorhexidine

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00516906). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.